Abstract:This work reports on the engineering of a liquid Z‐scheme heterojunction nanosonosensitizer‐based sonodynamic mitophagy inhibition strategy for inducing enhanced sonodynamic therapy (SDT) efficacy synergistic with self‐protective mitophagy inhibition against triple‐negative breast cancer, offering a promising "all‐in‐one" tumor‐killing paradigm. Sonodynamic therapy (SDT) has emerged as a potent therapeutic modality to generate intratumoral toxic reactive oxygen species (ROS) in combating refractory triple‐negative breast cancer (TNBC). However, its therapeutic efficacy is compromised due to pro‐survival cancer‐cell mitophagy to mitigate mitochondrial oxidative damage. Here, an "all‐in‐one" tumor‐therapeutic strategy that integrates nanosonosensitizer‐augmented noninvasive SDT with mitophagy inhibition is reported. This is achieved using a rationally constructed sonoactivated liquid Z‐scheme heterojunction that connects sonosensitizer PtCu3 nanocages and mitophagy‐blocking sonosensitizer BP nanosheets via an amphipathic organic linker (PEI‐PEG5000‐C18). The conjugated electron mediator (M, Cp*Rh(phen)Cl) is strategically positioned between the 2 sonosensitizers to facilitate electron transfer. This M‐based Z‐scheme configuration prolongs the separation of sonoactivated electron‐hole pairs, leading to efficient ROS generation upon ultrasound stimulation. Importantly, Cu2+ released from PtCu3 expedites BP degradation by reducing phosphorus vacancy formation energy, improving the overall biodegradability of BP‐M‐PtCu3 and favoring phosphate ions production. These ions elevate lysosomal pH, inhibiting the hydrolysis of damaged mitochondria within autophagic lysosomes, thus preventing cancer cell self‐preservation under oxidative stress and effectively eliminating TNBC. It is believe that the M‐based sonoactivated Z‐scheme heterojunction will be a promising sonosensitizer structure, and the sonodynamic mitophagy inhibition strategy offers valuable prospects for cancer treatment.

Intracellular Mutual Amplification of Oxidative Stress and Inhibition Multidrug Resistance for Enhanced Sonodynamic/Chemodynamic/Chemo Therapy

Tumor Metabolism‐Engineered Composite Nanoplatforms Potentiate Sonodynamic Therapy Via Reshaping Tumor Microenvironment and Facilitating Electron–Hole Pairs’ Separation

Polyoxometalate Modified by Zeolite Imidazole Framework for the Ph-Responsive Electrodynamic/Chemodynamic Therapy

Tumor microenvironment-regulated drug delivery system combined with sonodynamic therapy for the synergistic treatment of breast cancer

Multifunctional Oxygen-Generating Nanoflowers for Enhanced Tumor Therapy

Boosting Chemodynamic Therapy via a Synergy of Hypothermal Ablation and Oxidation Resistance Reduction

Nanoenzyme-Augmented Cancer Sonodynamic Therapy by Catalytic Tumor Oxygenation.

Multifunctional Composite Nanosystems for Precise/Enhanced Sonodynamic Oxidative Tumor Treatment

A cascade nanoreactor for enhancing sonodynamic therapy on colorectal cancer via synergistic ROS augment and autophagy blockage

One-Step Fabrication of Multifunctional PLGA-HMME-DTX@MnO2 Nanoparticles for Enhanced Chemo-Sonodynamic Antitumor Treatment

Defect Engineering Triggers Exceptional Sonodynamic Activity of Manganese Oxide Nanoparticles for Cancer Therapy

A Core-Shell Nanoplatform for Synergistic Enhanced Sonodynamic Therapy of Hypoxic Tumor via Cascaded Strategy

Biocatalysis of MnO2-mediated Nanosystem for Enhanced Multimodal Therapy and Real-time Tracking

Sonoactivated Z‐Scheme Heterojunction for Enhanced Sonodynamic Mitophagy Inhibition and Triple Negative Breast Cancer Treatment

Flower-Like MnO2 Nanoparticle-Based Dual GSH-Depleting Nanosystems for Chemo-/Chemodynamic/Sonodynamic Cancer Therapy

Tumor Microenvironment Modulation Platform Based on Composite Biodegradable Bismuth–Manganese Radiosensitizer for Inhibiting Radioresistant Hypoxic Tumors

A cascade nanoreactor for enhancing sonodynamic therapy on colorectal cancer<i> via</i> synergistic ROS augment and autophagy blockage

Redox Imbalance Triggered Intratumoral Cascade Reaction for Tumor “turn On” Imaging and Synergistic Therapy

Metalloporphyrin-Encapsulated Biodegradable Nanosystems for Highly Efficient Magnetic Resonance Imaging-Guided Sonodynamic Cancer Therapy

ROS-augmented and tumor-microenvironment responsive biodegradable nanoplatform for enhancing chemo-sonodynamic therapy

Ultrasmall Oxygen-Deficient Bimetallic Oxide MnWO Nanoparticles for Depletion of Endogenous GSH and Enhanced Sonodynamic Cancer Therapy.